Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Paper
Citations, authors & open-access status
4,676
Citations
2,018
Year
bronze
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
Robert J. Motzer
Author
Frede Donskov
Author
Howard Gurney
Author
Daniel Castellano
Author
Hans J. Hammers
Author
Saby George
Author
470M+ articles · free account